JayanshuJainMD

PubMed

• 1 citations
  Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to ...
  Hamza Hashmi, Shebli Atrash, Jayanshu Jain, Ghena Khasawneh, Meera Mohan, Zahra Mahmoudjafari, Wei Cui, Joseph McGuirk, Leyla Shune, Nausheen Ahmed, Al-Ola Abdallah> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 3 citations
  Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
  Rafee Talukder, Dimitrios Makrakis, Leonidas N Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Ivan De Kouchkovsky, Vadim S Koshkin, Joseph J Park, Ajjai Alva,...> ;Clinical Genitourinary Cancer. 2022 Apr 1
• 23 citations
  Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
  Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam, Christopher T Su, Ali Raza Khaki, Chelsea K Osterman, Michael J Glover...> ;Cancer. 2022 Mar 15
• 5 citations
  Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.
  Satyanarayana, G., Enriquez, K., Sun, T., Klein, E., Abidi, M., Advani, S., Awosika, J., Bakouny, Z., Bashir, B., Berg, S., Bernardes, M., Egan, P., Elkrief, A., Feldm...> ;Open Forum Infectious Diseases. 2022 Mar 1
• 3 citations
  Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
  Dimitrios Makrakis, Rafee Talukder, Leonidas Nikolaos Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Aj...> ;BJU International. 2021 Oct 25
• 18 citations
  Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes
  Park, J., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;BJU International. 2021 Aug 1
• 32 citations
  A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
  Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie J. Miller, Lucia Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. P...> ;European Urology Oncology. 2021 Jun 1
• 3 citations
  Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma.
  Josiah An, Vignesh T Packiam, Adithya Chennamadhavuni, Jordan Richards, Jayanshu Jain, Sarah L Mott, Rohan Garje> ;Frontiers in Oncology. 2021 Jan 1
• 7 citations
  Evaluation of Checkpoint Inhibitors in Cancer Patients With End-stage Renal Disease on Hemodialysis: Case Series and Review of the Literature.
  Jayanshu Jain, Jill Stein, Rohan Garje> ;Journal of Immunotherapy. 2020 Oct 1
• 69 citations
  Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
  Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Mehmet Asim Bilen, Victor Sacristan Santos, John Esther, Rafael Morales-Barrera, Michael Edward Devitt, Ariel...> ;Cancer. 2020 Mar 15
• 23 citations
  Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
  Natalie J. Miller, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Mehmet Asim Bilen, Victor Sacristan Santos, Neeraj Agarwal, Rafael Morales-Barrera, Michael Edward...> ;The Journal of Urology. 2020 Jan 23
• Join now to see all